Obsessive-compulsive symptoms interact with disorganization in influencing social functioning in schizophrenia

Schizophrenia Research
Matteo TonnaCarlo Marchesi

Abstract

Recent research has suggested a dual impact of obsessive-compulsive dimension on functioning in schizophrenia with a gradual transition from an improving to a worsening effect depending on obsessive-compulsive symptoms (OCS) severity (from mild to moderate-severe). Aim of the present study was to investigate whether this varying effect of OCS on functioning might be mediated or moderated by schizophrenia symptom dimensions or occur independently. Seventy-five patients affected by schizophrenia were administered the Structured Clinical Interview for DSM-IV Disorders, the Positive and Negative Syndrome Scale, the Yale-Brown Obsessive-Compulsive Scale and the Social and Occupational Functioning Assessment. The sample was divided into two groups according to the severity of OCS (absent/mild and moderate/high OCS group). In both groups, the effect of OCS on functioning was not mediated by their effect on positive, negative or disorganization symptoms. Conversely, a significant interaction between OCS and disorganization dimension was found: the dual effect of OCS on functioning occurred only among patients with low disorganization symptoms while it was no more apparent at high levels of disorganization. Data suggest that in patients...Continue Reading

References

Oct 1, 1989·Archives of General Psychiatry·M E ShentonH J Gale
Nov 1, 1989·Archives of General Psychiatry·W K GoodmanD S Charney
Jan 1, 1987·Schizophrenia Bulletin·S R KayL A Opler
Oct 1, 1957·The Journal of Mental Science·I ROSEN
Mar 3, 2005·The American Journal of Psychiatry·Nancy C AndreasenDaniel R Weinberger
Apr 1, 1949·The Psychiatric Quarterly·P HOCH, P POLATIN
Dec 24, 2008·Expert Review of Neurotherapeutics·Paul H Lysaker, Kriscinda A Whitney
Mar 31, 2009·Schizophrenia Research·Rajiv TandonMatcheri S Keshavan
Aug 12, 2009·The Australian and New Zealand Journal of Psychiatry·Karen O'ConnorAndrew Thompson
Jun 29, 2010·Comprehensive Psychiatry·Ahmet Tiryaki, Evrim Ozkorumak
May 17, 2011·European Psychiatry : the Journal of the Association of European Psychiatrists·A KarowUNKNOWN EGOFORS Initiative
Nov 1, 2011·Comprehensive Psychiatry·Michael PoyurovskyAbraham Weizman
Jun 30, 2012·The British Journal of Psychiatry : the Journal of Mental Science·M OorschotI Myin-Germeys
Jul 12, 2014·International Journal of Psychiatry in Clinical Practice·Alp ÜçokRaşit Tükel
Sep 5, 2014·JAMA Psychiatry·Sandra M MeierPreben B Mortensen
Oct 14, 2014·Comprehensive Psychiatry·Sugnyani DeviY C Janardhan Reddy
Feb 18, 2015·The Australian and New Zealand Journal of Psychiatry·Matteo TonnaCarlo Marchesi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Anxiety Disorders

Discover the latest research on anxiety disorders including agoraphobia, panic disorder, obsessive-compulsive disorder, and post-traumatic stress disorder here.